Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 516895, 6 pages
http://dx.doi.org/10.1155/2015/516895
Research Article

The Association of Serum IL-33 and sST2 with Breast Cancer

Oncology Department, The First Affiliated Hospital of Jiaxing University, Jiaxing 314001, China

Received 30 April 2015; Revised 27 August 2015; Accepted 27 August 2015

Academic Editor: Olav Lapaire

Copyright © 2015 Zhi-Ping Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Weigelt, J. L. Peterse, and L. J. van’t Veer, “Breast cancer metastasis: markers and models,” Nature Reviews Cancer, vol. 5, no. 8, pp. 591–602, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Hayakawa, M. Hayakawa, A. Kume, and S.-I. Tominaga, “Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation,” Journal of Biological Chemistry, vol. 282, no. 36, pp. 26369–26380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Tago, T. Noda, M. Hayakawa et al., “Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V,” Biochemical and Biophysical Research Communications, vol. 285, no. 5, pp. 1377–1383, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Schmitz, A. Owyang, E. Oldham et al., “IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines,” Immunity, vol. 23, no. 5, pp. 479–490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Liu, L. Zhu, X. Lu et al., “IL-33/ST2 pathway contributes to metastasis of human colorectal cancer,” Biochemical and Biophysical Research Communications, vol. 453, no. 3, pp. 486–492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D.-P. Lu, X.-Y. Zhou, L.-T. Yao et al., “Serum soluble ST2 is associated with ER-positive breast cancer,” BMC Cancer, vol. 14, article 198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L.-A. Hu, Y. Fu, D.-N. Zhang, and J. Zhang, “Serum IL-33 as a diagnostic and prognostic marker in non-small cell lung cancer,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 4, pp. 2563–2566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. I. P. Jovanovic, N. N. Pejnovic, G. D. Radosavljevic et al., “Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells,” International Journal of Cancer, vol. 134, no. 7, pp. 1669–1682, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Gillibert-Duplantier, B. Duthey, V. Sisirak et al., “Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis,” Oncogene, vol. 31, no. 30, pp. 3516–3524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. O. J. Scully, B.-H. Bay, G. Yip, and Y. Yu, “Breast cancer metastasis,” Cancer Genomics & Proteomics, vol. 9, no. 5, pp. 311–320, 2012. View at Google Scholar · View at Scopus
  12. H. F. Dvorak, “Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy,” Journal of Clinical Oncology, vol. 20, no. 21, pp. 4368–4380, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Ferrara, K. Houck, L. Jakeman, and D. W. Leung, “Molecular and biological properties of the vascular endothelial growth factor family of proteins,” Endocrine Reviews, vol. 13, no. 1, pp. 18–32, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. D. G. Gilbertson, M. E. Duff, J. W. West et al., “Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor,” The Journal of Biological Chemistry, vol. 276, no. 29, pp. 27406–27414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Zwerner and W. A. May, “PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors,” Oncogene, vol. 20, no. 5, pp. 626–633, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kelly, Y. Yan, R. L. Osborne et al., “Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases,” Clinical & Experimental Metastasis, vol. 16, no. 6, pp. 501–512, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Mareel, M. J. Oliveira, and I. Madani, “Cancer invasion and metastasis: interacting ecosystems,” Virchows Archiv, vol. 454, no. 6, pp. 599–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Hicklin and L. M. Ellis, “Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis,” Journal of Clinical Oncology, vol. 23, no. 5, pp. 1011–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. N. A. Lokker, C. M. Sullivan, S. J. Hollenbach, M. A. Israel, and N. A. Giese, “Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors,” Cancer Research, vol. 62, no. 13, pp. 3729–3735, 2002. View at Google Scholar · View at Scopus
  20. C. Anderberg, H. Li, L. Fredriksson et al., “Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts,” Cancer Research, vol. 69, no. 1, pp. 369–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Crawford, I. Kasman, L. Yu et al., “PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment,” Cancer Cell, vol. 15, no. 1, pp. 21–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Basset, J. P. Bellocq, C. Wolf et al., “A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas,” Nature, vol. 348, no. 6303, pp. 699–704, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ahmad, A. Hanby, E. Dublin et al., “Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression,” The American Journal of Pathology, vol. 152, no. 3, pp. 721–728, 1998. View at Google Scholar · View at Scopus